ASCN Ascom Holding AG

Ascom and AvaSure partner in AI-powered virtual nursing solutions for North America

Ascom and AvaSure partner in AI-powered virtual nursing solutions for North America

Baar, Switzerland, August 28, 2025



Ascom, a leading provider of clinical workflow and mobile communication solutions, and AvaSure, a leader in AI-powered virtual care, have signed a multi-year Interoperability Partner Agreement to integrate AvaSure’s Virtual Care Platform with Ascom’s Healthcare Platform suite and Myco™ devices. This collaboration will enable hospitals to streamline communication, enhance care team coordination, and deliver safer, more efficient patient care.



According to survey data, 74% of acute care hospital leaders indicate that virtual nursing plays a significant role in influencing key hospital metrics1. When considering metrics for the success of virtual care programs, several can be favorably impacted through integration with the Ascom Healthcare Platform.

The AvaSure platform delivers AI-powered virtual care solutions, including virtual nursing, virtual observation, and virtual visits, that help hospitals reduce costs, improve patient outcomes, and increase care team efficiency. Its AI-augmented capabilities, such as ambient monitoring for falls, operational and patient safety monitoring, and a virtual care assistant, further enhance clinical workflows. Supported by experienced care experts and built to meet enterprise IT standards, AvaSure’s proven solutions are trusted by more than 1,100 hospitals with over 5,000 deployments worldwide.



“Healthcare leaders are looking for integrated, intelligent solutions that improve care delivery without adding complexity,” said Adam McMullin, CEO of AvaSure. “Our partnership with Ascom is a strategic step toward building a more connected care environment where virtual care, communication, and clinical workflows seamlessly support frontline staff and elevate patient outcomes.”

“Integration between AvaSure’s and Ascom’s healthcare platforms allows near real-time virtual monitoring alerts from AvaSure to be routed through Ascom’s clinical workflow engine and sent to the appropriate caregiver(s) with contextual relevance and actionable data,” said Tobias Stanelle, Managing Director, Ascom Americas. “This interoperability facilitates care collaboration between virtual and in-person clinical staff, which leads to better informed decision making, improved response times, staff satisfaction, and patient outcomes.”



The partnership allows both companies to address the increasing demand in healthcare for integrated, vendor-neutral systems that connect clinical communication and monitoring technologies. The Ascom-AvaSure integration is available to mutual customers and can be implemented as part of broader alarm management or virtual care initiatives. 

Find more information on the partnership:

  • watch
  • watch Ascom’s with AvaSure - CEO Adam McMullin.

1AvaSure Insight Survey. Accessed Aug 7, 2025.  

Attachment



EN
28/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ascom Holding AG

 PRESS RELEASE

Ascom preliminary results 2025

Ascom preliminary results 2025 Ad hoc announcement pursuant to Art. 53 LRBaar (Switzerland), 15 January 2026Based on preliminary unaudited figures, Ascom reports for fiscal year 2025 net revenue of CHF 292.1 million, which is an increase of around 3.8% at constant currencies, and an EBITDA margin of around 11.5% to 12.0%. Ascom generated net revenue of CHF 292.1 million for fiscal year 2025 (2024: CHF 286.7 million), which reflects an increase of around 3.8% at constant currencies. At actual currencies, the generated revenue represents an increase of 1.9% compared to the previous year, bas...

 PRESS RELEASE

Ascom vorläufige Ergebnisse 2025

Ascom vorläufige Ergebnisse 2025 Ad hoc-Mitteilung gemäss Art. 53 KRBaar (Schweiz), 15. Januar 2026Basierend auf vorläufigen, ungeprüften Zahlen erzielte Ascom im Geschäftsjahr 2025 einen Umsatz von CHF 292,1 Mio., was einem Wachstum von rund 3,8% zu konstanten Wechselkursen entspricht, sowie eine EBITDA-Marge von rund 11,5% bis 12,0%. Ascom erreichte im Geschäftsjahr 2025 einen Nettoumsatz von CHF 292,1 Mio. (2024: CHF 286,7 Mio.). Im Vergleich zum Vorjahr entspricht dies einem Wachstum von rund 3,8% zu konstanten Wechselkursen und von 1,9% zu aktuellen Wechselkursen, basierend auf vorläu...

 PRESS RELEASE

Ascom ernennt David Hale zum neuen CEO

Ascom ernennt David Hale zum neuen CEO Ad hoc Mitteilung gemäss Art. 53 KRBaar, Schweiz, 9. Dezember 2025 Der Verwaltungsrat der Ascom Holding AG hat David Hale zum neuen CEO der Ascom Holding AG ernannt. David Hale verfügt über einen erstklassigen Leistungsausweis und mehr als zwanzig Jahre Führungserfahrung in der Technologie- und Industriebranche. Er tritt seine Position am 4. Februar 2026 an. Michael Reitermann gibt die Aufgaben des Interim-CEO zu diesem Zeitpunkt ab, bleibt aber weiterhin ordentliches Mitglied des Verwaltungsrats. David Hale verfügt über mehr als 25 Jahre internation...

 PRESS RELEASE

Ascom appoints David Hale as new CEO

Ascom appoints David Hale as new CEO Ad hoc announcement pursuant to Art. 53 LRBaar, Switzerland, December 9, 2025 David Hale, an executive leader with a proven track record and over two decades of technology and industrial expertise, has been appointed by the Board of Directors of Ascom Holding AG as the new CEO of the Ascom Group. David Hale will join Ascom on February 4, 2026. Michael Reitermann will step down as interim CEO at that time and remain an ordinary member of the Board of Directors. David Hale has more than 25 years of international leadership experience in the medical devic...

Ascom Holding AG: 1 director

A director at Ascom Holding AG bought 20,000 shares at 3.435CHF and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch